Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial Examining Dose-per-Fraction Escalation Using Intensity Modulated Radiation Therapy in the Treatment of Prostate Cancer

NCT00214097 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT00214097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00214097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial Examining Dose-per-Fraction Escalation Using Intensity Modulated Radiation Therapy in the Treatment of Prostate Cancer
Lead sponsor
University of Wisconsin, Madison
Phase
Phase 1/2
Overall status
Completed
Start date
October 14, 2002
Completion date
August 21, 2017
Enrollment
347 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer